Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of psychiatric research"
DOI: 10.1016/j.jpsychires.2022.03.057
Abstract: Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD). Treatment of MDD often entails a trial-and-error process of finding a suitable antidepressant and its appropriate dose.… read more here.
Keywords: major depressive; response; tricyclic antidepressants; antidepressants major ... See more keywords
Pharmacogenetics and the Response to Antidepressants in Major Depressive Disorder
Sign Up to like & getrecommendations! Published in 2025 at "Pharmaceuticals"
DOI: 10.3390/ph18091360
Abstract: Purpose: Genetic polymorphisms within specific genes play a role in both the genetic predisposition to Major Depressive Disorder (MDD) and the variation observed in responses to antidepressant treatments. Pharmacogenetics examines how these polymorphisms affect medication… read more here.
Keywords: treatment; antidepressants major; depressive disorder; response ... See more keywords